Advertisement
Advertisement

HBIO

HBIO logo

Harvard Bioscience Inc

6.89
USD
Sponsored
+0.10
+1.55%
May 08, 15:59 UTC -4
Closed
exchange

After-Market

6.90

0.00
+0.06%

HBIO Earnings Reports

Positive Surprise Ratio

HBIO beat 15 of 41 last estimates.

37%

Next Report

In 2 Days
Date of Next Report
May 12, 2026
Estimate for Q1 26 (Revenue/ EPS)
$21.62M
/
-$0.63
Implied change from Q4 25 (Revenue/ EPS)
-8.89%
/
--
Implied change from Q1 25 (Revenue/ EPS)
-0.69%
/
+530.00%

Harvard Bioscience Inc earnings per share and revenue

On Mar 12, 2026, HBIO reported earnings of 0.00 USD per share (EPS) for Q4 25, missing the estimate of 0.35 USD, resulting in a -100.00% surprise. Revenue reached 23.73 million, compared to an expected 23.56 million, with a 0.73% difference. The market reacted with a -2.58% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of -0.63 USD, with revenue projected to reach 21.62 million USD, implying an -- of --% EPS, and decrease of -8.89% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Bruker Corporation
Report Date
May 06, 2026 For Q1 26
Estimate
$0.23
Actual
$0.31
Surprise
+30.14%
FAQ
For Q4 2025, Harvard Bioscience Inc reported EPS of $0.00, missing estimates by -100%, and revenue of $23.73M, 0.73% above expectations.
The stock price moved down -2.58%, changed from $0.51 before the earnings release to $0.49 the day after.
The next earning report is scheduled for May 12, 2026.
Based on 4 analysts, Harvard Bioscience Inc is expected to report EPS of -$0.63 and revenue of $21.62M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement